Understanding how m6A mRNA methylation affects the immune response to bacterial infections
Roles of m6A mRNA Methylation in Innate Immunity
['FUNDING_R01'] · UNIVERSITY OF CHICAGO · NIH-10897813
This study is looking at how a specific chemical change in our cells affects the immune system, especially in immune cells called macrophages that help fight infections, to find ways to improve treatment for people with severe infections like sepsis.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10897813 on ClinicalTrials.gov |
What this research studies
This research investigates the role of m6A mRNA methylation in regulating the immune response, particularly in macrophages, which are crucial for fighting bacterial infections. By studying how this modification influences the production of pro-inflammatory cytokines during sepsis, the research aims to uncover mechanisms that could improve the resolution of inflammation. The approach involves genetic targeting of specific proteins involved in m6A methylation to observe their effects on immune function in a controlled laboratory setting. This could lead to new insights into how to better manage severe infections in patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are at risk of or currently experiencing sepsis due to Gram-negative bacterial infections.
Not a fit: Patients with non-bacterial infections or those not experiencing severe immune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for sepsis and other severe bacterial infections, potentially reducing mortality rates.
How similar studies have performed: Other research has shown promising results in understanding the role of m6A methylation in various biological processes, suggesting that this approach could yield valuable insights.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LI, YAN CHUN — UNIVERSITY OF CHICAGO
- Study coordinator: LI, YAN CHUN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bacterial Infections